Hematopoietic growth factor

Hematopoietic growth factors are a class of cytokines and glycoproteins that regulate hematopoiesis—the formation and development of blood cells within the bone marrow. These molecules interact with specific receptors on progenitor or precursor cells to promote their survival, proliferation, and differentiation into various blood cell lineages, including erythrocytes, leukocytes, and platelets. Clinically, hematopoietic growth factors are used to treat or prevent cytopenias (such as anemia, neutropenia, and thrombocytopenia) associated with chemotherapy, bone marrow failure syndromes, and chronic kidney disease. Major hematopoietic growth factors and their primary clinical analogs include erythropoietin (for red blood cells), granulocyte-colony stimulating factor/G-CSF (for neutrophils), granulocyte-macrophage colony-stimulating factor/GM-CSF (for granulocytes and macrophages), and thrombopoietin (for platelets)[1][2][3][4][7][10]. Notes on accuracy and conventions: - Hematopoietic growth factor is a family/class, not a single molecule; use of this term is non-specific, applying to many individual factors such as erythropoietin, G-CSF, etc.[1][2][3][7][10]. - is_incorrect: true because the query targets a whole class, not a single canonical molecule; best practice is to specify the individual factor of interest (e.g., "erythropoietin" or "granulocyte colony-stimulating factor") for structured information, not the family as a whole. - If a specific molecule is intended, structured data for each (e.g., erythropoietin, G-CSF, etc.) should be collected separately. - There is no universal canonical abbreviation because this is an umbrella term for a group of molecules. - "HGF" may also mean "hepatocyte growth factor," a completely different molecule, so avoid this unless context is clear.

Other names

Hemopoietic growth factorHGFHematopoietic cell growth factor

Stimulates hematopoietic cell lineages by binding to specific cell surface receptors and activating intracellular signaling pathways (primarily JAK/STAT), leading to increased production/survival/differentiation of target blood cell types